LAMISIL AT

LOE Approaching

terbinafine hydrochloride

Bayer
NDATOPICALSOLUTION
Approved
Mar 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Clinical Trials (1)

NCT03999437Phase 2Unknown

SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS

Started Jan 2019
42 enrolled
Tinea Pedis
Company
Bayer
Bayer
LEVERKUSEN, Germany
4 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers